Pluripotency without tumors?

Written byAlla Katsnelson

| 2 min read

Japanese researchers who linkurl:reprogrammed;http://www.the-scientist.com/blog/display/53873/ pluripotency into adult human skin cells say they have improved the technique, according to a linkurl:paper;http://www.nature.com/nbt published online today (Nov. 30) in Nature Biotechnology. linkurl:Shinya Yamanaka;http://www.frontier.kyoto-u.ac.jp/rc02/kyojuE.html of Kyoto University and his colleagues originally used four transcription factors to induce pluripotency in linkurl:mouse;http://www.the-scientist.com/blog/display/24307/ embryonic and adult fibroblast cells, and most recently, linkurl:adult human skin cells.;http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=18035408&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum But the process caused tumors in a significant percentage of the chimeric mice generated from the cells - a problem the researchers attributed to one of the four genes, c-Myc, which induces proliferation. In the current study, the researchers showed that pluripotent cells can be made from both mouse and human adult cells without introducing the c-Myc gene, by transducing just the other three. It's not that Myc isn't needed in the process, the authors noted in the paper; rather, they suggest that the other three genes may be spurring endogenous Myc activity. None of the 26 chimeras made from cells generated without c-Myc developed tumors within 100 days, compared to six out of 36 chimeras made from cells using all four genes. linkurl:James Thomson's;http://ink.primate.wisc.edu/~thomson/ group at the University of Wisconsin, Madison, also linkurl:reported;http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=18029452&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum reprogramming human cells last week, using a set of four transcription factors that did not include c-Myc. So far, though, they have used their approach in neonatal cells, but not adult cells. The Yamanaka group's study "suggests that tumour formation was indeed due to abnormal cMyc expression rather than some general problem of the reprogramming method," linkurl:Robin Lovell-Badge;http://www.nimr.mrc.ac.uk/devgen/lovell/ of the MRC National Institute for Medical Research in London, wrote in an Email to The Scientist. "However, they did not look thoroughly for tumours and screened relatively few animals, so more work is needed on this." So far, too, efficiency with this triple-gene method is much lower than with the original four genes; half of the experiments without c-Myc did not produce pluripotent cells at all, while experiments using the four genes almost always yielded pluripotent colonies. "Does this mean that it now only works with a rare cell type?" Lovell-Badge wrote. "As always, many more questions are posed than answered."

Pluripotency without tumors?

The Scientist ARCHIVES

Become a Member of

Meet the Author

Alla Katsnelson

Related Research Resources

Why Do We Feel Butterflies in the Stomach?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Research Roundtable: The Evolving World of Spatial Biology

Exploring the State of the Art in Gene Editing Techniques

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

Products

Product News

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel